Tuhura Biosciences Inc. (KTRA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Tuhura Biosciences Inc. (KTRA:NASDAQ), powered by AI.

Current Price
$2.14
Sector
Healthcare
What is the Tuhura Biosciences Inc. stock price forecast?

Tuhura Biosciences Inc. is currently trading at $2.14. View real-time AI analysis on Alpha Lenz.

What is Tuhura Biosciences Inc. insider trading activity?

View the latest insider trading data for Tuhura Biosciences Inc. on Alpha Lenz.

What is Tuhura Biosciences Inc.'s P/E ratio?

View Tuhura Biosciences Inc.'s valuation metrics on Alpha Lenz.

Tuhura Biosciences Inc.

NASDAQ · KTRA
$2.14-0.04(-1.83%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Tuhura Biosciences Inc.'s future dividend policy...
Alpha Chat Insight

Tuhura Biosciences Inc.'s ROE is -370.8%. Explore profitability and growth together.

Ask for details

Company Overview

Tuhura Biosciences Inc. is a biotechnology company involved in discovering and developing innovative therapies to address unmet medical needs. The company's primary function is to enhance the quality of life for patients by focusing on cutting-edge research and leveraging advanced technologies in drug discovery and development. Tuhura Biosciences operates at the intersection of healthcare and technology, influencing the biotechnology and pharmaceutical industries. Its research initiatives are geared towards understanding complex biological systems and translating this knowledge into actionable medical interventions. By harnessing the power of data-driven insights and precision medicine, Tuhura Biosciences plays a significant role in the market, contributing to the advancement of personalized healthcare solutions and offering potential breakthroughs in the treatment landscape for various diseases. Its presence underscores the growing momentum in the biosciences sector, as companies strive to bring new therapies from the laboratory to the clinic, ultimately aiming to improve patient outcomes globally.

CEOMr. Robert E. Hoffman B.B.A., CPA
SectorHealthcare
IndustryBiotechnology
Employees1

Company Statistics

FY 2024

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
1Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-163.44%ROA
-370.77%ROE
-166.02%ROIC

Financial Health

$4.91MCash & Cash Equivalents
$-2.46MNet Debt
65.08%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Tuhura Biosciences Inc. (ticker: KTRA) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 1 employees.

The current price is $2.14 with a P/E ratio of -x and P/B of -x.

ROE is -370.77%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Tuhura Biosciences Inc. (KTRA) Stock Forecast 2026 $2.14 — Price, Financials & Analyst Targets | Alpha Lenz